| Literature DB >> 30262770 |
Changbao Sun1,2, Yingying Li3,4, Songsong Cao5,6, Haimei Wang7,8, Chenggang Jiang9, Shiyue Pang10,11, Muhammad Altaf Hussain12,13, Juncai Hou14,15.
Abstract
In recent years, the overuse of antibiotics has become very serious. Many pathogenic bacteria have become resistant to them, with serious potential health consequences. Thus, it is urgent that we develop new antibiotic drugs. Antimicrobial peptides (AMPs) are important endogenous antibacterial molecules that contribute to immunity. Most have spectral antibacterial properties and do not confer drug resistance. In this paper, an 11-residue peptide (LFcinB18⁻28) with a sequence of KCRRWQWRMKK was modified by amino acid substitution to form a symmetrical amino acid sequence. The antibacterial activities and mechanisms of action of engineered peptides including KW-WK (KWRRWQWRRWK), FP-PF (FPRRWQWRRPF), FW-WF (FWRRWQWRRWF), and KK-KK (KKRRWQWRRKK) were investigated. The four engineered peptides could more effectively inhibit bacteria than the original peptide, LFcinB18⁻28. This suggested that a symmetrical amino acid sequence might enhance the antibacterial activity of AMPs. However, only peptides KW-WK, FP-PF, and KK-KK were safe; FW-WF displayed hemolytic activity. The engineered peptides shared cationic and amphipathic characteristics that facilitated interactions with the anionic microbial membranes, leading to disruption of membrane integrity and permeabilizing microbial membranes, resulting in cell death. Therefore, a symmetrical amino acid sequence and related structural parameters offer an alternative approach to the design of AMPs. This will provide a scientific basis for the design and synthesis of new AMPs.Entities:
Keywords: antibacterial activity; antibacterial peptides; bovine lactoferricin; mechanism; symmetrical amino acid sequences
Mesh:
Substances:
Year: 2018 PMID: 30262770 PMCID: PMC6213309 DOI: 10.3390/ijms19102951
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Peptide design and key physicochemical parameters.
| Peptides | Sequence | Theoretical MW | Measured MW a | Net Charge | μH b | H c | Purity |
|---|---|---|---|---|---|---|---|
| KW-WK | KWRRWQWRRWK-NH2 | 1772.1 | 1771.13 | +7 | 0.441 | 0.251 | 96.94% |
| FP-PF | FPRRWQWRRPF-NH2 | 1631.9 | 1630.94 | +5 | 0.159 | 0.478 | 97.58% |
| FW-WF | FWRRWQWRRRWF-NH2 | 1810.1 | 1809.70 | +6 | 0.054 | 0.609 | 97.31% |
| KK-KK | KKRRWQWRRKK-NH2 | 1656.0 | 1655.05 | +9 | 0.010 | −0.338 | 95.21% |
| LFcinB18–28 | KCRRWQWRMKK-NH2 | 1605.9 | 1605.02 | +7 | 0.420 | 0.095 | 95.81% |
a Molecular weight (MW) was measured by mass spectroscopy (MS); b The hydrophobic moment (μH) of a peptide is its hydrophobic moment relative to that of a perfectly amphipathic peptide. This yields a better measure of peptide amphipathicity using different scales; c The mean hydrophobicity (H) is the total hydrophobicity (sum of all residue hydrophobicity indices) divided by the number of residues.
Figure 1Helical wheel projections of the peptides. By default the output presents the hydrophilic residues as circles, hydrophobic residues as diamonds, and potentially positively charged as pentagons. Hydrophobicity is color-coded as well: the most hydrophobic residue is green, and the amount of green decreases proportionally to the hydrophobicity, with zero hydrophobicity coded as yellow. Hydrophilic residues are coded red, with pure red being the most hydrophilic (uncharged) residue and the amount of red decreasing proportionally to the hydrophilicity.
Figure 2The Circular Dichroism (CD) spectrum of each peptide. The mean residue ellipticity was plotted against wavelength. The values from three scans were averaged per sample, and the peptide concentrations were fixed at 40 µM. (A) KW-WK; (B) FP-PF; (C) FW-WF; (D) KK-KK; (E) LFcinB18-28.
Antimicrobial and hemolytic activities of the peptides.
| MIC a (μM) | |||||
|---|---|---|---|---|---|
| KW-WK | FP-PF | FW-WF | KK-KK | LFcinB18–28 | |
|
| |||||
| 4 | 4 | 4 | 32 | 16 | |
| 8 | 8 | 16 | 32 | 128 | |
| 16 | 64 | 16 | >128 | >128 | |
| 32 | 32 | 128 | >128 | >128 | |
| 16 | 16 | 8 | 128 | >128 | |
| 128 | 128 | >128 | 128 | >128 | |
|
| |||||
| 8 | 32 | >128 | >128 | >128 | |
| S. aureus ATCC 25923 | 32 | 32 | 16 | 128 | 128 |
| 8 | 64 | 8 | >128 | >128 | |
|
| >256 | >256 | 8 | >256 | >256 |
|
| 28.00 | 42.22 | 78.67 | 163.55 | 200.89 |
|
| 9.14 | 6.06 | 0.10 | 1.56 | 1.28 |
The final concentrations of peptides ranged from 0 μM to 256 μM. a Minimum inhibitory concentrations (MIC) are defined as the lowest concentration of peptide that inhibits bacterial growth; b Minimum hemolytic concentration (MHC) is the lowest concentration of peptide that causes 5% hemolysis of human red blood cells (hRBCs); c GM denotes the geometric mean of MIC values from all microbial strains in this table; d Therapeutic index (TI) is the ratio of the MHC to the geometric mean of all MICs. Larger values indicate greater cell selectivity.
Figure 3Hemolytic activity curves of each peptide against human red blood cells.
Figure 4Cytotoxicity of each peptide against HEK293 cells.
MIC values of antimicrobial peptides in the presence of physiological salts.
| Peptides | Na+ | K+ | Mg2+ | Ca2+ | Zn2+ | Fe3+ | NH4+ | Control |
|---|---|---|---|---|---|---|---|---|
| KW-WK | 8 | 4 | 8 | 8 | 8 | 4 | 8 | 4 |
| FP-PF | 64 | 8 | 8 | 8 | 8 | 4 | 8 | 4 |
| FW-WF | 8 | 4 | 4 | 8 | 4 | 4 | 2 | 4 |
| KK-KK | 16 | 16 | 64 | 16 | 8 | 8 | 8 | 32 |
| LFcinB18–28 | 16 | 16 | 16 | 16 | 8 | 4 | 8 | 16 |
The concentrations of salts were 150 mM NaCl, 4.5 mM KCl, 6 μM NH4Cl, 1 mM MgCl2, 1 mM MgCl2, 8 mM ZnCl3, 2.5 mM CaCl2 and 4 mM FeCl3.
MIC values of peptides following heating.
| Peptides | 100 °C | Control |
|---|---|---|
| KW-WK | 4 | 4 |
| FP-PF | 8 | 4 |
| FW-WF | 8 | 4 |
| KK-KK | >128 | 32 |
| LFcinB18–28 | 16 | 16 |
The final concentrations of peptides ranged from 0 μM to 256 μM.
MIC values of antimicrobial peptides in the presence of proteolytic enzymes.
| Peptides | Trypsin | Pepsin | Papain | Protease K | Control |
|---|---|---|---|---|---|
| KW-WK | >128 | 16 | 8 | 8 | 4 |
| FP-PF | 128 | 16 | 8 | 4 | 4 |
| FW-WF | >128 | >128 | 4 | 16 | 4 |
| KK-KK | >128 | >128 | >128 | >128 | 32 |
| LFcinB18–28 | >128 | >128 | >128 | >128 | 16 |
The final concentrations of peptides ranged from 0 μM to 256 μM.
Figure 5Uptake of NPN in E. coli UB1005 cells treated with different concentrations of antimicrobial peptides.
Figure 6Release of cytoplasmic β-galactosidase in E. coli UB1005 cells treated with antimicrobial peptides at concentrations of 1/2× MIC and 1× MIC.
Figure 7Cytoplasmic membrane depolarization of E. coli UB1005 follow treatment with the antimicrobial peptides at concentrations of 2 μM and 4 μM assessed by release of the membrane potential-sensitive dye diSC3-5.
Figure 8Membrane damage in E. coli ATCC25922 cells treated with the peptides as measured by an increase in fluorescence intensity of PI. (A) KW-WK 1× MIC; (B) KW-WK 1/2× MIC; (C) FP-PF 1× MIC; (D) FP-PF 1/2× MIC; (E) FW-WF 1× MIC; (F) FW-WF 1/2× MIC; (G) the control processed without peptides.
Figure 9SEM micrographs of E. coli ATCC25922 cells treated with the antimicrobial peptides. (A) KW-WK; (B) FP-PF; (C) FW-WF; (D) the control was processed without peptides.
Figure 10TEM micrographs of E. coli ATCC 25922 cells treated with the antimicrobial peptides. (A) KW-WK; (B) FP-PF; (C) FW-WF; (D) the control was processed without peptides.